You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 18, 2026

piperonyl butoxide; pyrethrins - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for piperonyl butoxide; pyrethrins and what is the scope of patent protection?

Piperonyl butoxide; pyrethrins is the generic ingredient in one branded drug marketed by Bayer Healthcare Llc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for piperonyl butoxide; pyrethrins
US Patents:0
Tradenames:1
Applicants:1
NDAs:1

US Patents and Regulatory Information for piperonyl butoxide; pyrethrins

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc RID MOUSSE piperonyl butoxide; pyrethrins AEROSOL;TOPICAL 021043-001 Mar 7, 2000 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Investment Scenario and Fundamentals Analysis for Piperonyl Butoxide and Pyrethrins

Last updated: February 20, 2026

What is the current market landscape for piperonyl butoxide and pyrethrins?

Piperonyl butoxide (PBO) and pyrethrins are key ingredients in insecticide formulations. Pyrethrins are natural compounds derived from Chrysanthemum flowers, effective against a broad spectrum of pests. PBO functions as a synergist, enhancing the potency of pyrethrins while inhibiting insect detoxification enzymes. The global market for pest control agents experienced compound annual growth rates (CAGR) of approximately 4.5% from 2018 to 2022, driven by increasing demand in residential, agricultural, and public health segments [1].

What are the supply chain dynamics?

The primary producers of pyrethrins are large-scale cultivators in India and Africa. Pyrethrins extraction relies on agricultural yield and climate conditions, leading to supply variability. PBO is synthesized primarily in China and India. Both ingredients have established manufacturing processes but face potential regulatory and environmental challenges that could impact output and cost.

What regulatory factors influence the market?

Regulatory agencies, such as the Environmental Protection Agency (EPA) in the U.S. and European Chemicals Agency (ECHA), evaluate safety and environmental impact. Pyrethrins are generally considered low in toxicity but require restrictions due to potential effects on non-target species. PBO has faced scrutiny for environmental persistence and potential endocrine-disrupting effects. New regulations could increase compliance costs or restrict usage, affecting market growth.

How does patent status influence market entry?

No recent patents restrict the production of pyrethrins, as extraction processes are well established. PBO's patents have expired or are nearing expiration, allowing generic manufacturing. This has led to increased competition and price erosion in recent years.

What are the key factors affecting profitability?

Profit margins depend on raw material costs, regulatory compliance expenses, and market demand. Raw material prices fluctuate based on agricultural yields and geopolitical factors. Regulatory compliance adds costs, potentially narrowing margins for producers, especially those operating in regions with strict environmental rules.

What are the main drivers for future investment?

Growing global insect resistance and demand for sustainable pest control products support ongoing demand. The COVID-19 pandemic increased product usage in disinfection, pushing formulations with PBO and pyrethrins into new segments. Innovation in biodegradable formulations and encapsulation technology could create new market opportunities but requires R&D investment.

How does competition affect the outlook?

Generic manufacturers dominate supply, keeping prices competitive. Incumbents with integrated supply chains and R&D capabilities can capture more market share through product differentiation. Patent cliffs and regulatory risks hinder higher-margin specialty formulations.


Profitability and Market Outlook

Factor Impact Notes
Raw Material Costs Variable Crop yields and geopolitical stability influence supply and prices
Regulatory Environment Risk Stricter policies can restrict use, increase costs
Competition Intensity Low barriers lead to high competition, suppressing prices
Innovation Opportunity R&D in formulations and delivery methods can command premium pricing
Global Demand Growth Increasing pest control needs in agriculture, public health, and consumer segments

Market analysts project the insecticide ingredients segment to grow at a CAGR of approximately 4% through 2027, driven by rising application from emerging economies and environmental sustainability commitments [2].

Investment considerations

  • Market maturity: Both PBO and pyrethrins face mature markets with high competition. Growth depends on innovation and regulatory landscape.
  • Supply chain risks: Reliance on agricultural crops introduces volatility.
  • Regulatory trends: Stricter environmental policies could impact supply and pricing.
  • R&D potential: Opportunities exist in biodegradable and controlled-release formulations, which could offer higher margins.

Key Takeaways

  • Supply chains for pyrethrins and PBO are established but susceptible to environmental and geopolitical risks.
  • The market is mature with price competition, but innovation in formulation presents growth opportunities.
  • Regulatory scrutiny presents both risks and opportunities; companies investing in compliance and sustainable practices may benefit.
  • Demand fuels growth across sectors, including agriculture, public health, and residential pest control.
  • Profitability is constrained by raw material costs and market competition, emphasizing the importance of operational efficiency and innovation.

FAQs

  1. What are the primary uses of piperonyl butoxide and pyrethrins?
    Pyrethrins serve as active ingredients in insecticides; PBO enhances their efficacy as a synergist. They are used in household sprays, agricultural products, and public health disinfection.

  2. How do regulatory changes impact supply and prices?
    Regulations restricting environmental or human health impacts can increase compliance costs, restrict usage, or ban certain formulations, affecting supply and prices.

  3. What are the main competitive advantages for producers?
    Access to stable raw material supplies, efficient manufacturing, R&D capabilities for formulation innovation, and compliance with environmental standards.

  4. Are there emerging markets for these ingredients?
    Yes; developing countries expanding their pest control infrastructure create additional demand, especially in agriculture and urban sanitation.

  5. What future technological advancements could affect the market?
    Development of biodegradable insecticides, controlled-release formulations, and eco-friendly synergists could disrupt current market dynamics and command premium pricing.


References

  1. MarketsandMarkets. (2022). Pest Control Market by Type, Application, and Region.
  2. Grand View Research. (2021). Insecticide Ingredients Market Size, Share & Trends Analysis.

[1] MarketsandMarkets, 2022.
[2] Grand View Research, 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.